Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Clinical trial NCT01107522 · UNKNOWN

Trial details

NCT number: NCT01107522
Sponsor: Tactical Therapeutics, Inc.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas

Start date: 2010-05-01
Primary completion: 2025-01-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.